THE use of Diamox in glaucoma logically follows Friedenwald's concept that the bicarbonate ion is secreted in the production of aqueous. Diamox is a powerful inhibitor of carbonic anhydrase and has been shown to be safe for human beings. By preventing, in part, the secretion of bicarbonate it diminishes aqueous production and consequently lowers intra-ocular pressure.
The use of Diamox in glaucoma was first reported by Becker (1954) and further annotated by Grant and Trotter (1954) .
The present paper is intended as a preliminary report of the first twenty cases of glaucoma treated with Diamox in the Ophthalmic Department of the Edinburgh Royal Infirmary.
Material
The patients treated comprised twelve cases of secondary glaucoma, six of congestive glaucoma, and two of chronic primary glaucoma. The particulars of age, sex, and previous history are given in Table I (overleaf).
The cases of secondary glaucoma included nine of uveitis with increased intraocular pressure (Cases 5, 7, 8, 10, 12, 13, 16, 18, 19) , of which three were also aphakic (Cases 12, 13, 18); one was secondary to an intumescent lens (Case 20), one was secondary to an intra-ocular foreign body with traumatic cataract (Case 11), and one followed perforating keratoplasty (Case 2).
The patients with congestive glaucoma included five cases of acute congestive glaucoma (Cases 3, 4, 9, 14, 15) and one of repeated subacute congestive episodes with peripheral anterior synechiae (Case 6).
In both patients with chronic simple glaucoma (Cases 1 and 17) operation was thought to be undesirable; Case 17 had had two previous drainage operations without adequate control, and Case 1 had already lost one eye through infection following a trephine operation.
In Congestive Glaucoma.-Of the six patients treated, three were considered controlled; one of these was controlled solely by Diamox (Case 4), whereas the other two (Cases 6 and 15) received Diamox and miotics but had not been controlled by the use of miotics alone. Two of the non-controlled cases showed so little improvement that operation was considered advisable (Cases 9 and 14); the sixth was only temporarily controlled (Case 3) and was subsequently operated upon.
Chronic Glaucoma.-Both patients treated with Diamox showed an adequate but only temporary reduction in pressure. In the first case (Case 1) the tension rose after 7 days of therapy and a trephine operation was carried out. The other case (Case 17) was controlled by Diamox for 8 weeks, but then the tension rose again and cyclodialysis was performed.
The detailed results are shown in Table I , and the cases are summarized in Table II.   TABLE II In all other cases 250 mg. Diamox was used orally every 6 hours with 30 gr. sodium bicarbonate. When the tension was controlled on this dosage, the dose of the drug was reduced to 250 mg. twice daily and later in the series to 125 mg. 6-hourly which was found to be more effective. After that the dosage may be further reduced to 125 mg. thrice or twice daily, and in some cases, especially of secondary glaucoma, the drug can be discontinued when the inflammatory process subsides.
The maintenance dose has to be worked out on a principle of trial and error. In one case 250 mg. 6-hourly was the only controlling dose; another required 250 mg. thrice daily, but most cases require less than that.
In the cases on a high maintenance dosage the serum potassium and sodium levels have remained within normal limits and the patients are well.
Side-Effects All the patients complained of tingling in the fingers and toes even when on small doses of Diamox. Some experienced polyuria and thirst but were not apparently inconvenienced. Two complained of dyspepsia. One, who had had a peptic ulcer previously (Case 4), discontinued the drug and was very fortunately controlled on miotics after that; the other is taking the Diamox with a glass of milk (Case 13).
Conclusions
(1) Diamox can exert a powerful effect in lowering intra-ocular pressure.
(2) It reduces ocular tension in various forms of glaucoma, either alone or in conjunction with other drugs.
(3) Diamox seems to be particularly valuable as a method of therapy in cases of secondary and congestive glaucoma.
(4) In chronic simple glaucoma the tension is reduced by Diamox, but only temporarily; further studies in this form of glaucoma are desirable. 
